nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—ovarian cancer	0.51	1	CbGaD
Cilazapril—ABCB1—Topotecan—ovarian cancer	0.0644	0.354	CbGbCtD
Cilazapril—ABCB1—Vinorelbine—ovarian cancer	0.0454	0.249	CbGbCtD
Cilazapril—ABCB1—Paclitaxel—ovarian cancer	0.0319	0.175	CbGbCtD
Cilazapril—ABCB1—Docetaxel—ovarian cancer	0.023	0.127	CbGbCtD
Cilazapril—ABCB1—Doxorubicin—ovarian cancer	0.0172	0.0945	CbGbCtD
Cilazapril—ACE—vein—ovarian cancer	0.0141	0.243	CbGeAlD
Cilazapril—SLC15A1—epithelium—ovarian cancer	0.00303	0.0524	CbGeAlD
Cilazapril—SLC15A1—endometrium—ovarian cancer	0.00272	0.0469	CbGeAlD
Cilazapril—ACE—embryo—ovarian cancer	0.00266	0.046	CbGeAlD
Cilazapril—ACE—epithelium—ovarian cancer	0.00217	0.0375	CbGeAlD
Cilazapril—ACE—decidua—ovarian cancer	0.00205	0.0355	CbGeAlD
Cilazapril—SLC15A1—vagina—ovarian cancer	0.00203	0.0352	CbGeAlD
Cilazapril—ACE—endometrium—ovarian cancer	0.00195	0.0337	CbGeAlD
Cilazapril—SLC15A2—uterine cervix—ovarian cancer	0.00188	0.0324	CbGeAlD
Cilazapril—ACE—gonad—ovarian cancer	0.00181	0.0312	CbGeAlD
Cilazapril—SLC15A2—endometrium—ovarian cancer	0.0017	0.0293	CbGeAlD
Cilazapril—ACE—female reproductive system—ovarian cancer	0.00161	0.0279	CbGeAlD
Cilazapril—ACE—bone marrow—ovarian cancer	0.00152	0.0263	CbGeAlD
Cilazapril—ACE—female gonad—ovarian cancer	0.00147	0.0254	CbGeAlD
Cilazapril—SLC15A2—female reproductive system—ovarian cancer	0.00141	0.0243	CbGeAlD
Cilazapril—ACE—testis—ovarian cancer	0.0013	0.0225	CbGeAlD
Cilazapril—SLC15A2—female gonad—ovarian cancer	0.00128	0.0221	CbGeAlD
Cilazapril—SLC15A2—vagina—ovarian cancer	0.00127	0.022	CbGeAlD
Cilazapril—SLC15A2—testis—ovarian cancer	0.00114	0.0196	CbGeAlD
Cilazapril—ABCB1—myometrium—ovarian cancer	0.000974	0.0168	CbGeAlD
Cilazapril—ACE—lymph node—ovarian cancer	0.000944	0.0163	CbGeAlD
Cilazapril—ABCB1—embryo—ovarian cancer	0.000937	0.0162	CbGeAlD
Cilazapril—SLC15A2—lymph node—ovarian cancer	0.000823	0.0142	CbGeAlD
Cilazapril—ABCB1—epithelium—ovarian cancer	0.000764	0.0132	CbGeAlD
Cilazapril—ABCB1—uterine cervix—ovarian cancer	0.000758	0.0131	CbGeAlD
Cilazapril—ABCB1—decidua—ovarian cancer	0.000722	0.0125	CbGeAlD
Cilazapril—ABCB1—endometrium—ovarian cancer	0.000685	0.0118	CbGeAlD
Cilazapril—ABCB1—gonad—ovarian cancer	0.000636	0.011	CbGeAlD
Cilazapril—ABCB1—uterus—ovarian cancer	0.000632	0.0109	CbGeAlD
Cilazapril—ABCB1—female reproductive system—ovarian cancer	0.000568	0.00982	CbGeAlD
Cilazapril—ABCB1—bone marrow—ovarian cancer	0.000536	0.00927	CbGeAlD
Cilazapril—ABCB1—female gonad—ovarian cancer	0.000517	0.00893	CbGeAlD
Cilazapril—ABCB1—vagina—ovarian cancer	0.000514	0.00888	CbGeAlD
Cilazapril—ABCB1—testis—ovarian cancer	0.000458	0.00792	CbGeAlD
Cilazapril—ABCB1—lymph node—ovarian cancer	0.000332	0.00574	CbGeAlD
Cilazapril—Perindopril—ABCB1—ovarian cancer	0.0003	0.396	CrCbGaD
Cilazapril—Lisinopril—ABCB1—ovarian cancer	0.000265	0.349	CrCbGaD
Cilazapril—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000249	0.000997	CcSEcCtD
Cilazapril—Bronchitis—Epirubicin—ovarian cancer	0.000249	0.000995	CcSEcCtD
Cilazapril—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000248	0.000995	CcSEcCtD
Cilazapril—Anaemia—Docetaxel—ovarian cancer	0.000247	0.000988	CcSEcCtD
Cilazapril—Anorexia—Paclitaxel—ovarian cancer	0.000245	0.000981	CcSEcCtD
Cilazapril—Vomiting—Vinorelbine—ovarian cancer	0.000243	0.000973	CcSEcCtD
Cilazapril—Dysuria—Epirubicin—ovarian cancer	0.000242	0.000967	CcSEcCtD
Cilazapril—Neutropenia—Epirubicin—ovarian cancer	0.000242	0.000967	CcSEcCtD
Cilazapril—Rash—Vinorelbine—ovarian cancer	0.000241	0.000965	CcSEcCtD
Cilazapril—Dermatitis—Vinorelbine—ovarian cancer	0.000241	0.000964	CcSEcCtD
Cilazapril—Hypotension—Paclitaxel—ovarian cancer	0.00024	0.000962	CcSEcCtD
Cilazapril—Headache—Vinorelbine—ovarian cancer	0.000239	0.000959	CcSEcCtD
Cilazapril—Syncope—Docetaxel—ovarian cancer	0.000239	0.000958	CcSEcCtD
Cilazapril—Leukopenia—Docetaxel—ovarian cancer	0.000239	0.000957	CcSEcCtD
Cilazapril—Pollakiuria—Epirubicin—ovarian cancer	0.000239	0.000956	CcSEcCtD
Cilazapril—Palpitations—Docetaxel—ovarian cancer	0.000236	0.000945	CcSEcCtD
Cilazapril—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000236	0.000944	CcSEcCtD
Cilazapril—Loss of consciousness—Docetaxel—ovarian cancer	0.000235	0.000939	CcSEcCtD
Cilazapril—Pancreatitis—Doxorubicin—ovarian cancer	0.000234	0.000939	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000234	0.000938	CcSEcCtD
Cilazapril—Hyperglycaemia—Epirubicin—ovarian cancer	0.000233	0.000933	CcSEcCtD
Cilazapril—Cough—Docetaxel—ovarian cancer	0.000233	0.000933	CcSEcCtD
Cilazapril—Angina pectoris—Doxorubicin—ovarian cancer	0.000233	0.000933	CcSEcCtD
Cilazapril—Insomnia—Paclitaxel—ovarian cancer	0.000232	0.000931	CcSEcCtD
Cilazapril—Paraesthesia—Paclitaxel—ovarian cancer	0.000231	0.000924	CcSEcCtD
Cilazapril—Hypertension—Docetaxel—ovarian cancer	0.00023	0.000923	CcSEcCtD
Cilazapril—Bronchitis—Doxorubicin—ovarian cancer	0.00023	0.000921	CcSEcCtD
Cilazapril—Dyspnoea—Paclitaxel—ovarian cancer	0.000229	0.000918	CcSEcCtD
Cilazapril—Somnolence—Paclitaxel—ovarian cancer	0.000229	0.000915	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000228	0.000915	CcSEcCtD
Cilazapril—Chest pain—Docetaxel—ovarian cancer	0.000227	0.00091	CcSEcCtD
Cilazapril—Myalgia—Docetaxel—ovarian cancer	0.000227	0.00091	CcSEcCtD
Cilazapril—Arthralgia—Docetaxel—ovarian cancer	0.000227	0.00091	CcSEcCtD
Cilazapril—Nausea—Vinorelbine—ovarian cancer	0.000227	0.000909	CcSEcCtD
Cilazapril—Renal failure—Epirubicin—ovarian cancer	0.000226	0.000907	CcSEcCtD
Cilazapril—Dyspepsia—Paclitaxel—ovarian cancer	0.000226	0.000906	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000226	0.000904	CcSEcCtD
Cilazapril—Conjunctivitis—Epirubicin—ovarian cancer	0.000224	0.000897	CcSEcCtD
Cilazapril—Dysuria—Doxorubicin—ovarian cancer	0.000224	0.000895	CcSEcCtD
Cilazapril—Neutropenia—Doxorubicin—ovarian cancer	0.000224	0.000895	CcSEcCtD
Cilazapril—Decreased appetite—Paclitaxel—ovarian cancer	0.000223	0.000895	CcSEcCtD
Cilazapril—Dry mouth—Docetaxel—ovarian cancer	0.000222	0.00089	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000222	0.000888	CcSEcCtD
Cilazapril—Fatigue—Paclitaxel—ovarian cancer	0.000222	0.000887	CcSEcCtD
Cilazapril—Pollakiuria—Doxorubicin—ovarian cancer	0.000221	0.000884	CcSEcCtD
Cilazapril—Constipation—Paclitaxel—ovarian cancer	0.00022	0.00088	CcSEcCtD
Cilazapril—Pain—Paclitaxel—ovarian cancer	0.00022	0.00088	CcSEcCtD
Cilazapril—Confusional state—Docetaxel—ovarian cancer	0.00022	0.00088	CcSEcCtD
Cilazapril—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000218	0.000874	CcSEcCtD
Cilazapril—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000218	0.000872	CcSEcCtD
Cilazapril—Oedema—Docetaxel—ovarian cancer	0.000218	0.000872	CcSEcCtD
Cilazapril—Epistaxis—Epirubicin—ovarian cancer	0.000217	0.00087	CcSEcCtD
Cilazapril—Sinusitis—Epirubicin—ovarian cancer	0.000216	0.000865	CcSEcCtD
Cilazapril—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000216	0.000864	CcSEcCtD
Cilazapril—Agranulocytosis—Epirubicin—ovarian cancer	0.000215	0.000861	CcSEcCtD
Cilazapril—Shock—Docetaxel—ovarian cancer	0.000214	0.000858	CcSEcCtD
Cilazapril—Thrombocytopenia—Docetaxel—ovarian cancer	0.000213	0.000854	CcSEcCtD
Cilazapril—Tachycardia—Docetaxel—ovarian cancer	0.000213	0.000851	CcSEcCtD
Cilazapril—Feeling abnormal—Paclitaxel—ovarian cancer	0.000212	0.000848	CcSEcCtD
Cilazapril—Skin disorder—Docetaxel—ovarian cancer	0.000212	0.000847	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000211	0.000846	CcSEcCtD
Cilazapril—Bradycardia—Epirubicin—ovarian cancer	0.000211	0.000843	CcSEcCtD
Cilazapril—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00021	0.000842	CcSEcCtD
Cilazapril—Renal failure—Doxorubicin—ovarian cancer	0.00021	0.000839	CcSEcCtD
Cilazapril—Anorexia—Docetaxel—ovarian cancer	0.000208	0.000831	CcSEcCtD
Cilazapril—Rhinitis—Epirubicin—ovarian cancer	0.000207	0.00083	CcSEcCtD
Cilazapril—Conjunctivitis—Doxorubicin—ovarian cancer	0.000207	0.00083	CcSEcCtD
Cilazapril—Hypoaesthesia—Epirubicin—ovarian cancer	0.000206	0.000824	CcSEcCtD
Cilazapril—Pharyngitis—Epirubicin—ovarian cancer	0.000205	0.000822	CcSEcCtD
Cilazapril—Urinary tract disorder—Epirubicin—ovarian cancer	0.000204	0.000818	CcSEcCtD
Cilazapril—Urticaria—Paclitaxel—ovarian cancer	0.000204	0.000818	CcSEcCtD
Cilazapril—Hypotension—Docetaxel—ovarian cancer	0.000204	0.000815	CcSEcCtD
Cilazapril—Abdominal pain—Paclitaxel—ovarian cancer	0.000203	0.000814	CcSEcCtD
Cilazapril—Urethral disorder—Epirubicin—ovarian cancer	0.000203	0.000812	CcSEcCtD
Cilazapril—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000202	0.000807	CcSEcCtD
Cilazapril—Epistaxis—Doxorubicin—ovarian cancer	0.000201	0.000805	CcSEcCtD
Cilazapril—Sinusitis—Doxorubicin—ovarian cancer	0.0002	0.000801	CcSEcCtD
Cilazapril—Visual impairment—Epirubicin—ovarian cancer	0.000199	0.000798	CcSEcCtD
Cilazapril—Agranulocytosis—Doxorubicin—ovarian cancer	0.000199	0.000797	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000198	0.000795	CcSEcCtD
Cilazapril—Insomnia—Docetaxel—ovarian cancer	0.000197	0.000789	CcSEcCtD
Cilazapril—Paraesthesia—Docetaxel—ovarian cancer	0.000196	0.000783	CcSEcCtD
Cilazapril—Erythema multiforme—Epirubicin—ovarian cancer	0.000196	0.000783	CcSEcCtD
Cilazapril—Bradycardia—Doxorubicin—ovarian cancer	0.000195	0.00078	CcSEcCtD
Cilazapril—Dyspnoea—Docetaxel—ovarian cancer	0.000194	0.000778	CcSEcCtD
Cilazapril—Enalapril—ABCB1—ovarian cancer	0.000194	0.256	CrCbGaD
Cilazapril—Somnolence—Docetaxel—ovarian cancer	0.000194	0.000775	CcSEcCtD
Cilazapril—Tinnitus—Epirubicin—ovarian cancer	0.000193	0.000772	CcSEcCtD
Cilazapril—Cardiac disorder—Epirubicin—ovarian cancer	0.000192	0.000769	CcSEcCtD
Cilazapril—Flushing—Epirubicin—ovarian cancer	0.000192	0.000769	CcSEcCtD
Cilazapril—Rhinitis—Doxorubicin—ovarian cancer	0.000192	0.000768	CcSEcCtD
Cilazapril—Dyspepsia—Docetaxel—ovarian cancer	0.000192	0.000768	CcSEcCtD
Cilazapril—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00019	0.000762	CcSEcCtD
Cilazapril—Pharyngitis—Doxorubicin—ovarian cancer	0.00019	0.000761	CcSEcCtD
Cilazapril—Decreased appetite—Docetaxel—ovarian cancer	0.000189	0.000758	CcSEcCtD
Cilazapril—Hypersensitivity—Paclitaxel—ovarian cancer	0.000189	0.000758	CcSEcCtD
Cilazapril—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000189	0.000757	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000188	0.000753	CcSEcCtD
Cilazapril—Fatigue—Docetaxel—ovarian cancer	0.000188	0.000752	CcSEcCtD
Cilazapril—Angiopathy—Epirubicin—ovarian cancer	0.000188	0.000751	CcSEcCtD
Cilazapril—Urethral disorder—Doxorubicin—ovarian cancer	0.000188	0.000751	CcSEcCtD
Cilazapril—Immune system disorder—Epirubicin—ovarian cancer	0.000187	0.000748	CcSEcCtD
Cilazapril—Pain—Docetaxel—ovarian cancer	0.000186	0.000746	CcSEcCtD
Cilazapril—Constipation—Docetaxel—ovarian cancer	0.000186	0.000746	CcSEcCtD
Cilazapril—Chills—Epirubicin—ovarian cancer	0.000186	0.000743	CcSEcCtD
Cilazapril—Arrhythmia—Epirubicin—ovarian cancer	0.000185	0.00074	CcSEcCtD
Cilazapril—Visual impairment—Doxorubicin—ovarian cancer	0.000184	0.000738	CcSEcCtD
Cilazapril—Asthenia—Paclitaxel—ovarian cancer	0.000184	0.000738	CcSEcCtD
Cilazapril—Alopecia—Epirubicin—ovarian cancer	0.000183	0.000732	CcSEcCtD
Cilazapril—Pruritus—Paclitaxel—ovarian cancer	0.000182	0.000728	CcSEcCtD
Cilazapril—Erythema multiforme—Doxorubicin—ovarian cancer	0.000181	0.000725	CcSEcCtD
Cilazapril—Feeling abnormal—Docetaxel—ovarian cancer	0.00018	0.000719	CcSEcCtD
Cilazapril—Tinnitus—Doxorubicin—ovarian cancer	0.000178	0.000714	CcSEcCtD
Cilazapril—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000178	0.000713	CcSEcCtD
Cilazapril—Flushing—Doxorubicin—ovarian cancer	0.000178	0.000711	CcSEcCtD
Cilazapril—Cardiac disorder—Doxorubicin—ovarian cancer	0.000178	0.000711	CcSEcCtD
Cilazapril—Flatulence—Epirubicin—ovarian cancer	0.000177	0.00071	CcSEcCtD
Cilazapril—Tension—Epirubicin—ovarian cancer	0.000177	0.000707	CcSEcCtD
Cilazapril—Dysgeusia—Epirubicin—ovarian cancer	0.000176	0.000706	CcSEcCtD
Cilazapril—Diarrhoea—Paclitaxel—ovarian cancer	0.000176	0.000704	CcSEcCtD
Cilazapril—Nervousness—Epirubicin—ovarian cancer	0.000175	0.0007	CcSEcCtD
Cilazapril—Angiopathy—Doxorubicin—ovarian cancer	0.000174	0.000695	CcSEcCtD
Cilazapril—Muscle spasms—Epirubicin—ovarian cancer	0.000173	0.000693	CcSEcCtD
Cilazapril—Immune system disorder—Doxorubicin—ovarian cancer	0.000173	0.000692	CcSEcCtD
Cilazapril—Abdominal pain—Docetaxel—ovarian cancer	0.000172	0.00069	CcSEcCtD
Cilazapril—Chills—Doxorubicin—ovarian cancer	0.000172	0.000688	CcSEcCtD
Cilazapril—Arrhythmia—Doxorubicin—ovarian cancer	0.000171	0.000685	CcSEcCtD
Cilazapril—Dizziness—Paclitaxel—ovarian cancer	0.00017	0.000681	CcSEcCtD
Cilazapril—Alopecia—Doxorubicin—ovarian cancer	0.000169	0.000677	CcSEcCtD
Cilazapril—Ill-defined disorder—Epirubicin—ovarian cancer	0.000167	0.000669	CcSEcCtD
Cilazapril—Anaemia—Epirubicin—ovarian cancer	0.000166	0.000666	CcSEcCtD
Cilazapril—Flatulence—Doxorubicin—ovarian cancer	0.000164	0.000657	CcSEcCtD
Cilazapril—Tension—Doxorubicin—ovarian cancer	0.000163	0.000655	CcSEcCtD
Cilazapril—Vomiting—Paclitaxel—ovarian cancer	0.000163	0.000654	CcSEcCtD
Cilazapril—Dysgeusia—Doxorubicin—ovarian cancer	0.000163	0.000653	CcSEcCtD
Cilazapril—Malaise—Epirubicin—ovarian cancer	0.000162	0.00065	CcSEcCtD
Cilazapril—Rash—Paclitaxel—ovarian cancer	0.000162	0.000649	CcSEcCtD
Cilazapril—Dermatitis—Paclitaxel—ovarian cancer	0.000162	0.000648	CcSEcCtD
Cilazapril—Nervousness—Doxorubicin—ovarian cancer	0.000162	0.000648	CcSEcCtD
Cilazapril—Vertigo—Epirubicin—ovarian cancer	0.000162	0.000648	CcSEcCtD
Cilazapril—Syncope—Epirubicin—ovarian cancer	0.000161	0.000646	CcSEcCtD
Cilazapril—Leukopenia—Epirubicin—ovarian cancer	0.000161	0.000645	CcSEcCtD
Cilazapril—Headache—Paclitaxel—ovarian cancer	0.000161	0.000645	CcSEcCtD
Cilazapril—Hypersensitivity—Docetaxel—ovarian cancer	0.000161	0.000643	CcSEcCtD
Cilazapril—Muscle spasms—Doxorubicin—ovarian cancer	0.00016	0.000641	CcSEcCtD
Cilazapril—Palpitations—Epirubicin—ovarian cancer	0.000159	0.000637	CcSEcCtD
Cilazapril—Loss of consciousness—Epirubicin—ovarian cancer	0.000158	0.000634	CcSEcCtD
Cilazapril—Cough—Epirubicin—ovarian cancer	0.000157	0.000629	CcSEcCtD
Cilazapril—Asthenia—Docetaxel—ovarian cancer	0.000156	0.000626	CcSEcCtD
Cilazapril—Hypertension—Epirubicin—ovarian cancer	0.000155	0.000622	CcSEcCtD
Cilazapril—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000155	0.000619	CcSEcCtD
Cilazapril—Pruritus—Docetaxel—ovarian cancer	0.000154	0.000617	CcSEcCtD
Cilazapril—Anaemia—Doxorubicin—ovarian cancer	0.000154	0.000617	CcSEcCtD
Cilazapril—Chest pain—Epirubicin—ovarian cancer	0.000153	0.000614	CcSEcCtD
Cilazapril—Myalgia—Epirubicin—ovarian cancer	0.000153	0.000614	CcSEcCtD
Cilazapril—Arthralgia—Epirubicin—ovarian cancer	0.000153	0.000614	CcSEcCtD
Cilazapril—Anxiety—Epirubicin—ovarian cancer	0.000153	0.000612	CcSEcCtD
Cilazapril—Nausea—Paclitaxel—ovarian cancer	0.000153	0.000611	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000152	0.00061	CcSEcCtD
Cilazapril—Discomfort—Epirubicin—ovarian cancer	0.000151	0.000606	CcSEcCtD
Cilazapril—Malaise—Doxorubicin—ovarian cancer	0.00015	0.000602	CcSEcCtD
Cilazapril—Dry mouth—Epirubicin—ovarian cancer	0.00015	0.0006	CcSEcCtD
Cilazapril—Vertigo—Doxorubicin—ovarian cancer	0.00015	0.000599	CcSEcCtD
Cilazapril—Syncope—Doxorubicin—ovarian cancer	0.000149	0.000598	CcSEcCtD
Cilazapril—Leukopenia—Doxorubicin—ovarian cancer	0.000149	0.000597	CcSEcCtD
Cilazapril—Diarrhoea—Docetaxel—ovarian cancer	0.000149	0.000597	CcSEcCtD
Cilazapril—Confusional state—Epirubicin—ovarian cancer	0.000148	0.000593	CcSEcCtD
Cilazapril—Palpitations—Doxorubicin—ovarian cancer	0.000147	0.000589	CcSEcCtD
Cilazapril—Oedema—Epirubicin—ovarian cancer	0.000147	0.000588	CcSEcCtD
Cilazapril—Loss of consciousness—Doxorubicin—ovarian cancer	0.000146	0.000586	CcSEcCtD
Cilazapril—Cough—Doxorubicin—ovarian cancer	0.000145	0.000582	CcSEcCtD
Cilazapril—Shock—Epirubicin—ovarian cancer	0.000145	0.000579	CcSEcCtD
Cilazapril—Dizziness—Docetaxel—ovarian cancer	0.000144	0.000577	CcSEcCtD
Cilazapril—Thrombocytopenia—Epirubicin—ovarian cancer	0.000144	0.000576	CcSEcCtD
Cilazapril—Hypertension—Doxorubicin—ovarian cancer	0.000144	0.000576	CcSEcCtD
Cilazapril—Tachycardia—Epirubicin—ovarian cancer	0.000143	0.000574	CcSEcCtD
Cilazapril—Skin disorder—Epirubicin—ovarian cancer	0.000143	0.000571	CcSEcCtD
Cilazapril—Hyperhidrosis—Epirubicin—ovarian cancer	0.000142	0.000569	CcSEcCtD
Cilazapril—Chest pain—Doxorubicin—ovarian cancer	0.000142	0.000568	CcSEcCtD
Cilazapril—Myalgia—Doxorubicin—ovarian cancer	0.000142	0.000568	CcSEcCtD
Cilazapril—Arthralgia—Doxorubicin—ovarian cancer	0.000142	0.000568	CcSEcCtD
Cilazapril—Anxiety—Doxorubicin—ovarian cancer	0.000141	0.000566	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000141	0.000564	CcSEcCtD
Cilazapril—Discomfort—Doxorubicin—ovarian cancer	0.00014	0.000561	CcSEcCtD
Cilazapril—Anorexia—Epirubicin—ovarian cancer	0.00014	0.000561	CcSEcCtD
Cilazapril—Dry mouth—Doxorubicin—ovarian cancer	0.000139	0.000555	CcSEcCtD
Cilazapril—Vomiting—Docetaxel—ovarian cancer	0.000139	0.000555	CcSEcCtD
Cilazapril—Rash—Docetaxel—ovarian cancer	0.000137	0.00055	CcSEcCtD
Cilazapril—Hypotension—Epirubicin—ovarian cancer	0.000137	0.00055	CcSEcCtD
Cilazapril—Dermatitis—Docetaxel—ovarian cancer	0.000137	0.000549	CcSEcCtD
Cilazapril—Confusional state—Doxorubicin—ovarian cancer	0.000137	0.000549	CcSEcCtD
Cilazapril—Headache—Docetaxel—ovarian cancer	0.000136	0.000546	CcSEcCtD
Cilazapril—Oedema—Doxorubicin—ovarian cancer	0.000136	0.000544	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000134	0.000536	CcSEcCtD
Cilazapril—Shock—Doxorubicin—ovarian cancer	0.000134	0.000536	CcSEcCtD
Cilazapril—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000133	0.000533	CcSEcCtD
Cilazapril—Insomnia—Epirubicin—ovarian cancer	0.000133	0.000532	CcSEcCtD
Cilazapril—Tachycardia—Doxorubicin—ovarian cancer	0.000133	0.000531	CcSEcCtD
Cilazapril—Skin disorder—Doxorubicin—ovarian cancer	0.000132	0.000529	CcSEcCtD
Cilazapril—Paraesthesia—Epirubicin—ovarian cancer	0.000132	0.000528	CcSEcCtD
Cilazapril—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000131	0.000526	CcSEcCtD
Cilazapril—Dyspnoea—Epirubicin—ovarian cancer	0.000131	0.000525	CcSEcCtD
Cilazapril—Somnolence—Epirubicin—ovarian cancer	0.000131	0.000523	CcSEcCtD
Cilazapril—Anorexia—Doxorubicin—ovarian cancer	0.00013	0.000519	CcSEcCtD
Cilazapril—Nausea—Docetaxel—ovarian cancer	0.000129	0.000518	CcSEcCtD
Cilazapril—Dyspepsia—Epirubicin—ovarian cancer	0.000129	0.000518	CcSEcCtD
Cilazapril—Decreased appetite—Epirubicin—ovarian cancer	0.000128	0.000511	CcSEcCtD
Cilazapril—Hypotension—Doxorubicin—ovarian cancer	0.000127	0.000509	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000127	0.000508	CcSEcCtD
Cilazapril—Fatigue—Epirubicin—ovarian cancer	0.000127	0.000507	CcSEcCtD
Cilazapril—Constipation—Epirubicin—ovarian cancer	0.000126	0.000503	CcSEcCtD
Cilazapril—Pain—Epirubicin—ovarian cancer	0.000126	0.000503	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000124	0.000496	CcSEcCtD
Cilazapril—Insomnia—Doxorubicin—ovarian cancer	0.000123	0.000492	CcSEcCtD
Cilazapril—Paraesthesia—Doxorubicin—ovarian cancer	0.000122	0.000489	CcSEcCtD
Cilazapril—Dyspnoea—Doxorubicin—ovarian cancer	0.000121	0.000485	CcSEcCtD
Cilazapril—Feeling abnormal—Epirubicin—ovarian cancer	0.000121	0.000485	CcSEcCtD
Cilazapril—Somnolence—Doxorubicin—ovarian cancer	0.000121	0.000484	CcSEcCtD
Cilazapril—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00012	0.000481	CcSEcCtD
Cilazapril—Dyspepsia—Doxorubicin—ovarian cancer	0.00012	0.000479	CcSEcCtD
Cilazapril—Decreased appetite—Doxorubicin—ovarian cancer	0.000118	0.000473	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000117	0.00047	CcSEcCtD
Cilazapril—Fatigue—Doxorubicin—ovarian cancer	0.000117	0.000469	CcSEcCtD
Cilazapril—Urticaria—Epirubicin—ovarian cancer	0.000117	0.000467	CcSEcCtD
Cilazapril—Constipation—Doxorubicin—ovarian cancer	0.000116	0.000466	CcSEcCtD
Cilazapril—Pain—Doxorubicin—ovarian cancer	0.000116	0.000466	CcSEcCtD
Cilazapril—Abdominal pain—Epirubicin—ovarian cancer	0.000116	0.000465	CcSEcCtD
Cilazapril—Feeling abnormal—Doxorubicin—ovarian cancer	0.000112	0.000449	CcSEcCtD
Cilazapril—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000111	0.000445	CcSEcCtD
Cilazapril—Hypersensitivity—Epirubicin—ovarian cancer	0.000108	0.000433	CcSEcCtD
Cilazapril—Urticaria—Doxorubicin—ovarian cancer	0.000108	0.000432	CcSEcCtD
Cilazapril—Abdominal pain—Doxorubicin—ovarian cancer	0.000107	0.00043	CcSEcCtD
Cilazapril—Asthenia—Epirubicin—ovarian cancer	0.000105	0.000422	CcSEcCtD
Cilazapril—Pruritus—Epirubicin—ovarian cancer	0.000104	0.000416	CcSEcCtD
Cilazapril—Diarrhoea—Epirubicin—ovarian cancer	0.000101	0.000403	CcSEcCtD
Cilazapril—Hypersensitivity—Doxorubicin—ovarian cancer	0.0001	0.000401	CcSEcCtD
Cilazapril—Asthenia—Doxorubicin—ovarian cancer	9.76e-05	0.000391	CcSEcCtD
Cilazapril—Dizziness—Epirubicin—ovarian cancer	9.72e-05	0.000389	CcSEcCtD
Cilazapril—Pruritus—Doxorubicin—ovarian cancer	9.62e-05	0.000385	CcSEcCtD
Cilazapril—Vomiting—Epirubicin—ovarian cancer	9.34e-05	0.000374	CcSEcCtD
Cilazapril—Diarrhoea—Doxorubicin—ovarian cancer	9.3e-05	0.000372	CcSEcCtD
Cilazapril—Rash—Epirubicin—ovarian cancer	9.27e-05	0.000371	CcSEcCtD
Cilazapril—Dermatitis—Epirubicin—ovarian cancer	9.26e-05	0.000371	CcSEcCtD
Cilazapril—Headache—Epirubicin—ovarian cancer	9.21e-05	0.000369	CcSEcCtD
Cilazapril—Dizziness—Doxorubicin—ovarian cancer	8.99e-05	0.00036	CcSEcCtD
Cilazapril—Nausea—Epirubicin—ovarian cancer	8.73e-05	0.000349	CcSEcCtD
Cilazapril—Vomiting—Doxorubicin—ovarian cancer	8.64e-05	0.000346	CcSEcCtD
Cilazapril—Rash—Doxorubicin—ovarian cancer	8.57e-05	0.000343	CcSEcCtD
Cilazapril—Dermatitis—Doxorubicin—ovarian cancer	8.56e-05	0.000343	CcSEcCtD
Cilazapril—Headache—Doxorubicin—ovarian cancer	8.52e-05	0.000341	CcSEcCtD
Cilazapril—Nausea—Doxorubicin—ovarian cancer	8.08e-05	0.000323	CcSEcCtD
